Viewing Study NCT05839951


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-02-23 @ 4:54 AM
Study NCT ID: NCT05839951
Status: COMPLETED
Last Update Posted: 2025-11-12
First Post: 2023-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer (mCRC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colon rectal cancer View
None Chemotherapy View
None Targeted medicine View
None Regorafenib View
None TAS-102 View